Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.
Laack E, Dickgreber N, Müller T, Knuth A, Benk J, Lorenz C, Gieseler F, Dürk H, Engel-Riedel W, Dalhoff K, Kortsik C, Graeven U, Burk M, Dierlamm T, Welte T, Burkholder I, Edler L, Hossfeld DK; German and Swiss Lung Cancer Study Group. Laack E, et al. Among authors: welte t. J Clin Oncol. 2004 Jun 15;22(12):2348-56. doi: 10.1200/JCO.2004.10.576. J Clin Oncol. 2004. PMID: 15197195 Clinical Trial.
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.
Rosell R, Robinet G, Szczesna A, Ramlau R, Constenla M, Mennecier BC, Pfeifer W, O'Byrne KJ, Welte T, Kolb R, Pirker R, Chemaissani A, Perol M, Ranson MR, Ellis PA, Pilz K, Reck M. Rosell R, et al. Among authors: welte t. Ann Oncol. 2008 Feb;19(2):362-9. doi: 10.1093/annonc/mdm474. Epub 2007 Oct 17. Ann Oncol. 2008. PMID: 17947225 Free article. Clinical Trial.
[Pharmacotherapy of severe acute respiratory syndrome (SARS)].
von Hagen L, Pletz MW, Dickgreber N, Golpon H, Bauer TT, Zabel P, Welte T, Groneberg DA. von Hagen L, et al. Among authors: welte t. Pneumologie. 2006 Nov;60(11):694-700. doi: 10.1055/s-2006-944278. Pneumologie. 2006. PMID: 17109267 Review. German.
[Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults].
Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H. Höffken G, et al. Among authors: welte t. Dtsch Med Wochenschr. 2010 Feb;135(8):359-65. doi: 10.1055/s-0030-1249171. Epub 2010 Feb 17. Dtsch Med Wochenschr. 2010. PMID: 20166002 German. No abstract available.
Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
Welte T, Petermann W, Schürmann D, Bauer TT, Reimnitz P; MOXIRAPID Study Group. Welte T, et al. Clin Infect Dis. 2005 Dec 15;41(12):1697-705. doi: 10.1086/498149. Epub 2005 Nov 10. Clin Infect Dis. 2005. PMID: 16288390 Clinical Trial.
Ampicillin/sulbactam in elderly patients with community-acquired pneumonia.
Majcher-Peszynska J, Loebermann M, Klammt S, Frimmel S, Mundkowski RG, Welte T, Reisinger EC, Drewelow B; CAPNETZ Study Group. Majcher-Peszynska J, et al. Among authors: welte t. Infection. 2014 Feb;42(1):79-87. doi: 10.1007/s15010-013-0518-8. Epub 2013 Aug 1. Infection. 2014. PMID: 23904004
1,258 results